CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Gel +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02102867
NCT02102867N/ACompleted
CompareCT.gov

Evaluating User Perceptions and Experiences of Dual Compartment Microbicide Formulations. Project 5.1: Developing Rectal USPE Measures

The Miriam Hospital·interventional·Posted Apr 3, 2014·Updated Feb 5, 2026

In Brief

A clinical study evaluating Gel, Cream, and 1 other intervention for Microbicide Delivery System Perceptibility and Acceptability. Completed, enrolled 18 participants across 1 site.

Detailed Summary

The purpose of this study is to: (a) adapt existing vaginal USPE items/instruments for evaluation of similar elements of rectal compartment use; (b) develop these scales using 3 distinct semi-solid formulations that represent a range of physicochemical and rheological properties of microbicides that are currently being designed for dual compartment use; and (c) develop novel USPE instruments to capture the experience of product use in the context of receptive anal intercourse (RAI) in both male and female cohorts.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMicrobicide Delivery System Perceptibility and Acceptability
CountriesUnited States
CollaboratorsImQuest Pharmaceuticals, Inc., National Institute of Allergy and Infectious Diseases (NIAID)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 3, 2014
Enrollment StartApr 1, 2014
Primary CompletionMar 1, 2015
Study CompletionApr 1, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 12.2 years ago

Interventions

Gelother

10mL

Creamother

10mL

Liquidother

10mL